Sea You at Fetch Long Beach
|Articles|October 1, 2006

Canine Blood Test

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds, the company says.

In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease.

NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states, according to the company.

For fastest response, visit

www.vdxinstitute.com


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.